About the Company
mpm is an early-stage life sciences venture investing firm with a track record of identifying and building world-class companies that seek to cure major diseases by translating scientific innovations into positive clinical outcomes. mpm’s portfolio of companies aims to revolutionize the face of medicine across multiple areas including cancer, neuroscience, metabolic disorders, and regenerative medicine. with its deep experience, dedicated team of operating executives, and distinguished medical and scientific advisory board, mpm is powering novel medical breakthroughs that transform patient lives.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ONCR News
Why Oncorus Shares Are Trading Lower By 25%; Here Are 20 Stocks Moving Premarket
Oncorus, Inc. (NASDAQ: ONCR) fell 24.9% to $0.0735 in pre-market. On June 7, Oncorus board unanimously approved dissolution and liquidation of company pursuant to a plan of liquidation and ...
Oncorus (NASDAQ: ONCR)
Oncorus, Inc. engages in the research and development of a viral immunotherapy platform. It develops an immunotherapy platform to treat cancer such as oncolytic Herpes Simplex Virus Platform and ...
Oncorus, Inc. Common Stock (ONCR)
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...
IPO Launch: Oncorus Targets $87 Million U.S. IPO
Oncorus intends to raise $87 million in gross proceeds from an IPO of 5.8 million shares of its common stock, offered at a proposed midpoint price of $15.00 per share.
Why ToughBuilt Industries Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Oncorus, Inc. (OTC: ONCR) shares dropped 54.4% to $0.0550. ToughBuilt Industries, Inc. (NASDAQ: TBLT) shares fell 46.4% to $0.30 after the company priced its 10,975,611 share offering at $0.41 per ...
X Financial Stock (NYSE:XYF), Quotes and News Summary
Gainers Oncorus, Inc. (NASDAQ: ONCR) shares rose 90% to $0.38 in pre-market trading after dropping around 17% on Thursday. Oncorus recently posted a narrower-than-expected quarterly loss.
Todd Foley's Net Worth
Todd Foley has an estimated net worth of $598 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., iTeos Therapeutics, Inc., TriVascular ...
RFL Rafael Holdings, Inc.
Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in ...
About Inc.com | Everything You Need to Know to Grow and Start Your Business
Inc. is the voice of the American entrepreneur. We inspire, inform, and document the most fascinating people in business: the risk-takers, the innovators, and the ultra-driven go-getters that ...
Elite Pharmaceuticals, Inc. (ELTP)
Elite Pharmaceuticals, Inc. (PNK:ELTP) Q3 2024 Earnings Call Transcript February 15, 2024 Elite Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the ...
Etsy Inc.
1 Day ETSY -0.46% DJIA 0.67% S&P 500 0.87% Retail/Wholesale 0.37% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the ...
Oncorus, Inc. Common Stock (ONCR)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...
Loading the latest forecasts...